• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Immunol . The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease

tetano

Editor, Senior Moderator
Clin Immunol


. 2024 Mar 7:110178.
doi: 10.1016/j.clim.2024.110178. Online ahead of print. The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease

Wenhui Guo[SUP] 1 [/SUP], Junhao Luo[SUP] 2 [/SUP], Song Zhao[SUP] 2 [/SUP], Li Li[SUP] 2 [/SUP], Wenge Xing[SUP] 3 [/SUP], Rongbao Gao[SUP] 4 [/SUP]



Affiliations
Abstract

Controlling the excessive inflammatory response is one of the key ways to reduce the severity and mortality of severe influenza virus infections. RAGE is involved in inflammatory responses and acute lung injuries. Here, we investigated the role of RAGE and its potential application as a target for severe influenza treatment through serological correlation analysis for influenza patients, and treatment with the RAGE inhibitor FPS-ZM1 on A549 cells or mice with influenza A (H1N1) infection. The results showed high levels of RAGE were correlated with immunopathological injury and severity of influenza, and FPS-ZM1 treatment increased the viability of A549 cells with influenza A infection and decreased morbidity and mortality of influenza A virus infection in mice. The RAGE/NF-κb inflammatory signaling pathway is a major targeting pathway for FPS-ZM1 treatment in severe influenza. These findings provide further insights into the immune injury of severe influenza and a potential targeting candidate for the disease treatment.

Keywords: Inflammatory injury; Influenza virus; Inhibitor; Pathogenesis; RAGE; Severe infection.

 
Back
Top Bottom